Article

The Whirlwind of Metastatic Breast Cancer

Author(s):

Editor’s Note: This piece was submitted by a contributing writer and does not represent the views of CURE Media Group.

I am a 47-year-old wife and mother of two daughters, and I have stage 4 metastatic breast cancer. I was diagnosed de novo metastatic disease (which means stage 4 at first diagnosis) on Christmas Day 2014, in an emergency room of a rural town. The shock I felt is indescribable. I never went through early stage cancer, and it was terrifying to hear these exact words from an ER doctor: "I'm so sorry, you are 100 percent riddled with tumors." These were not the words that brought me to my knees. It was the confirmation by an oncologist that did.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.